These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 37342873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis.
    Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui YM.
    J Clin Pharm Ther; 2020 Oct; 45(5):904-917. PubMed ID: 32107837
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.
    Health Technol Assess; 2001 Oct; 5(26):1-149. PubMed ID: 11701099
    [Abstract] [Full Text] [Related]

  • 5. Inhaled magnesium sulfate in the treatment of acute asthma.
    Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, Powell C.
    Cochrane Database Syst Rev; 2017 Nov 28; 11(11):CD003898. PubMed ID: 29182799
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease.
    Antoniu SA.
    Expert Opin Biol Ther; 2013 Feb 28; 13(2):257-68. PubMed ID: 23282002
    [Abstract] [Full Text] [Related]

  • 7. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review.
    Zhang S, King D, Rosen VM, Ismaila AS.
    Int J Chron Obstruct Pulmon Dis; 2020 Feb 28; 15():417-438. PubMed ID: 32161454
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M, Leggett R, Pang C, Charles S, Gillett B, Prime D.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec 28; 28(6):498-506. PubMed ID: 26372465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D, de Backer W, Hamilton M, Cahn A, Preece A, Kelleher D, Baines A, Moore A, Brealey N, Moynihan J.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec 28; 28(6):486-97. PubMed ID: 26372467
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP.
    Lancet Respir Med; 2013 Nov 28; 1(9):714-27. PubMed ID: 24429275
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE, Chenoweth JA, Pearson SJ, Murin S.
    Expert Opin Pharmacother; 2020 Feb 28; 21(2):213-231. PubMed ID: 31955671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist.
    Dekhuijzen PNR, Levy ML, Corrigan CJ, Hadfield RM, Roche N, Usmani OS, Barnes PJ, Scullion JE, Lavorini F, Corbetta L, Kocks JWH, Cosio BG, Buhl R, Pedersen SE, ADMIT Working Group.
    J Allergy Clin Immunol Pract; 2022 Jul 28; 10(7):1813-1824.e1. PubMed ID: 35364340
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.